PDE-4 inhibitor now available as steroid free option for atopic dermatitis

Crisaborole (Staquis) is now available in Australia for the treatment of mild to moderate atopic dermatitis in adults and children from two years of age, according to manufacturer Pfizer.  The topical phosphodiesterase-4 (PDE-4) inhibitor provides a steroid free option which may appeal to some patients or their parents, it said in a media statement. However ...

Already a member?

Login to keep reading.

© 2021 the limbic